Cerence Inc. (CRNC) Key Metrics
CRNC valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $403.9M
- Enterprise value
- $425.4M
- P/E (TTM)
- —
- Forward P/E
- 44.2
- PEG ratio
- —
- Price / sales
- 1.3 10-yr median 2.1
- Price / book
- 2.2 10-yr median 1.2
- EV / EBITDA
- 10.8 10-yr median 49.7
- Dividend yield
- —
- Beta
- 3.05
CRNC key metrics, FY2016–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsCRNC valuation Price multiples at each fiscal year-end price.
Price / sales+440.0%
2.1
FY2025 · hover or tap a bar for each year
FY2016FY2025
Price / book+284.1%
3.6
FY2025 · hover or tap a bar for each year
FY2016FY2025
EV / EBITDA
57.0
FY2025 · hover or tap a bar for each year
FY2016FY2025
Price / free cash flow+6.9%
11.5
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow yield−0.6 pts
8.7%
FY2025 · hover or tap a bar for each year
FY2016FY2025
CRNC returns How much profit the business earns on the capital it uses.
Return on equity+127.9 pts
−12.8%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Return on invested capital−2.7 pts
3.4%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Return on assets+56.0 pts
−2.8%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow margin+14.9 pts
18.6%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Asset turnover+14.0%
0.38
FY2025 · hover or tap a bar for each year
FY2016FY2025
CRNC per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−26.8%
$5.83
FY2025 · hover or tap a bar for each year
FY2016FY2025
Earnings per share
−$0.43
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow per share+270.1%
$1.08
FY2025 · hover or tap a bar for each year
FY2016FY2025
Book value per share+3.0%
$3.49
FY2025 · hover or tap a bar for each year
FY2016FY2025
Shares outstanding+3.7%
43.2M
FY2025 · hover or tap a bar for each year
FY2016FY2025
CRNC financial health Debt, liquidity and how easily interest is covered.
Debt / equity−27.0%
1.53
FY2025 · hover or tap a bar for each year
FY2016FY2025
Net debt−$25.4M
$142.8M
FY2025 · hover or tap a bar for each year
FY2016FY2025
Net debt / EBITDA
11.95
FY2025 · hover or tap a bar for each year
FY2016FY2025
Current ratio+50.3%
1.84
FY2025 · hover or tap a bar for each year
FY2016FY2025
Interest coverage−65.2%
1.3
FY2025 · hover or tap a bar for each year
FY2016FY2025
Debt / assets−13.1%
0.37
FY2025 · hover or tap a bar for each year
FY2016FY2025
CRNC efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+20 days
88 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
Days payables outstanding−30 days
13 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
Cash conversion cycle+50 days
76 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
Capex / revenue+4.2 pts
5.7%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Dividends + buybacks / FCF−75.8 pts
5.1%
FY2025 · hover or tap a bar for each year
FY2016FY2025
CRNC valuation history
Fiscal year-endToday10-year median
CRNC returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CRNC debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CRNC cash returned to shareholders
DividendsBuybacksFree cash flow
CRNC price vs earnings per share
Share price at year-endEPS (right axis)
CRNC key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $538.0M | $131.2M | $819.2M | $617.2M | $3.78B | $1.78B | $627.9M | — | — | — |
| Enterprise value | $680.8M | $299.4M | $998.1M | $788.9M | $3.91B | $1.93B | $646.9M | — | — | — |
| P/E ratio | — | — | — | — | 82.3 | — | 6.3 | — | — | — |
| Price / sales | 2.1 | 0.4 | 2.8 | 1.9 | 9.8 | 5.4 | 2.1 | — | — | — |
| Price / book | 3.6 | 0.9 | 1.2 | 0.9 | 3.7 | 1.9 | 0.6 | — | — | — |
| Price / free cash flow | 11.5 | 10.8 | 345.1 | — | 60.6 | 69.1 | 7.5 | — | — | — |
| Price / operating cash flow | 8.8 | 7.6 | 109.3 | — | 50.8 | 39.7 | 7.1 | — | — | — |
| EV / sales | 2.7 | 0.9 | 3.4 | 2.4 | 10.1 | 5.8 | 2.1 | — | — | — |
| EV / EBITDA | 57.0 | — | — | — | 42.5 | 64.9 | 16.2 | — | — | — |
| EV / free cash flow | 14.5 | 24.5 | 420.4 | — | 62.7 | 74.8 | 7.7 | — | — | — |
| Earnings yield | −3.5% | −448.3% | −6.9% | −50.4% | 1.2% | −1.0% | 16.0% | — | — | — |
| Free cash flow yield | 8.7% | 9.3% | 0.3% | −3.2% | 1.7% | 1.4% | 13.3% | — | — | — |
| Dividend yield | — | — | 28.7% | 1.0% | 0.0% | 8.6% | 24.4% | — | — | — |
| Shareholder yield (dividends + buybacks) | 0.4% | 7.5% | 29.2% | 9.0% | 1.2% | 9.1% | 24.4% | — | — | — |
| Share price at fiscal year-end | $12.46 | $3.15 | $20.37 | $15.75 | $96.11 | $48.87 | $17.25 | — | — | — |
| Per share | ||||||||||
| Revenue per share | $5.83 | $7.96 | $7.32 | $8.37 | $9.85 | $9.09 | $8.33 | $7.61 | $6.73 | $5.80 |
| Earnings per share | −$0.43 | −$14.12 | −$1.40 | −$7.93 | $1.17 | −$0.50 | $2.75 | $0.16 | $1.30 | $0.96 |
| Operating cash flow per share | $1.42 | $0.41 | $0.19 | −$0.05 | $1.89 | $1.23 | $2.42 | $3.17 | $2.66 | $3.13 |
| Free cash flow per share | $1.08 | $0.29 | $0.06 | −$0.50 | $1.59 | $0.71 | $2.30 | $2.99 | $2.53 | $2.90 |
| Cash per share | $2.03 | $3.05 | $2.74 | $2.94 | $4.04 | $4.06 | — | — | — | — |
| Book value per share | $3.49 | $3.39 | $17.28 | $18.19 | $26.27 | $26.29 | $29.35 | $27.30 | $27.41 | $27.80 |
| Tangible book value per share | −$3.44 | −$3.78 | −$5.21 | −$4.79 | −$3.10 | −$5.93 | −$3.21 | −$5.81 | −$3.54 | −$3.23 |
| Dividends per share | — | — | $5.84 | $0.16 | $0.00 | $4.20 | $4.20 | $4.20 | $4.20 | — |
| Capex per share | $0.33 | $0.12 | $0.13 | $0.45 | $0.31 | $0.52 | $0.12 | $0.18 | $0.13 | $0.23 |
| Debt per share | $5.33 | $7.09 | $7.19 | $7.32 | $7.38 | $8.14 | $0.52 | $0.04 | $0.58 | $0.58 |
| Shares outstanding | 43.2M | 41.6M | 40.2M | 39.2M | 39.3M | 36.4M | 36.4M | 36.4M | 36.4M | 36.4M |
| Change in shares outstanding | +3.7% | +3.5% | +2.6% | −0.3% | +7.9% | +0.1% | +0.0% | 0.0% | 0.0% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −12.8% | −140.7% | −8.0% | −35.6% | 4.6% | −1.8% | 9.7% | 0.6% | 4.7% | 3.5% |
| Return on invested capital (ROIC) | 3.4% | 6.2% | −1.4% | 3.0% | 5.5% | 2.8% | 3.5% | 2.7% | 4.8% | 3.6% |
| Return on assets (ROA) | −2.8% | −58.8% | −4.3% | −20.6% | 2.7% | −1.2% | 7.0% | 0.4% | 3.6% | 2.7% |
| Return on tangible assets | −5.6% | −145.6% | −14.3% | −74.4% | 8.3% | −3.6% | 33.5% | 3.1% | 22.6% | 21.3% |
| Free cash flow margin | 18.6% | 3.7% | 0.8% | −6.0% | 16.1% | 7.8% | 27.5% | 39.3% | 37.6% | 50.0% |
| Income quality (OCF / net income) | — | — | — | — | 1.62 | — | 0.88 | 19.60 | 2.05 | 3.26 |
| Financial health | ||||||||||
| Total debt | $230.3M | $295.2M | $289.3M | $286.8M | $289.8M | $296.6M | $19.1M | $1.5M | $21.2M | $21.1M |
| Cash & short-term investments | $87.5M | $127.0M | $110.4M | $115.2M | $158.9M | $147.7M | — | — | — | — |
| Net debt | $142.8M | $168.2M | $179.0M | $171.7M | $130.9M | $148.9M | $19.1M | $1.5M | $21.2M | $21.1M |
| Debt / equity | 1.53 | 2.09 | 0.42 | 0.40 | 0.28 | 0.31 | 0.02 | 0.00 | 0.02 | 0.02 |
| Debt / assets | 0.37 | 0.42 | 0.22 | 0.22 | 0.17 | 0.18 | 0.01 | 0.00 | 0.02 | 0.02 |
| Net debt / EBITDA | 11.95 | — | — | — | 1.42 | 5.01 | 0.48 | 0.02 | 0.26 | 0.32 |
| Current ratio | 1.84 | 1.22 | 1.52 | 1.55 | 1.74 | 1.25 | 0.72 | 0.68 | 0.86 | 0.74 |
| Quick ratio | 1.84 | 1.22 | 1.48 | 1.55 | 1.74 | 1.25 | 0.72 | 0.68 | 0.86 | 0.74 |
| Interest coverage | 1.3 | 3.7 | -1.0 | 2.7 | 4.7 | 1.7 | 0.7 | — | — | — |
| Working capital | $85.1M | $48.7M | $77.6M | $80.5M | $121.7M | $50.5M | −$36.8M | −$38.8M | −$13.6M | −$20.5M |
| Invested capital | $293.5M | $309.3M | $873.8M | $884.6M | $1.16B | $1.11B | $1.09B | $994.8M | $1.02B | $1.03B |
| Tangible asset value | −$148.3M | −$157.5M | −$209.3M | −$187.6M | −$121.9M | −$216.1M | −$116.8M | −$211.4M | −$128.9M | −$117.6M |
| Net current asset value | −$293.6M | −$295.8M | −$377.0M | −$378.0M | −$386.7M | −$480.5M | −$323.4M | −$321.3M | −$257.8M | −$222.5M |
| Graham number | — | — | — | — | $26.27 | — | $42.65 | $9.96 | $28.31 | $24.51 |
| Graham net-net per share | −$8.07 | −$9.30 | −$11.01 | −$11.65 | −$12.24 | −$14.95 | −$10.07 | −$9.62 | −$7.78 | −$6.60 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $234.7M | $6.2M | $0 | $153.0M | $153.0M | $153.0M | $153.0M | — |
| Share buybacks (net) | $2.4M | $9.9M | $4.9M | $49.0M | $45.8M | $9.4M | — | — | — | — |
| Dividend payout ratio | — | — | — | — | 0.0% | — | 152.6% | — | 323.6% | — |
| Dividends + buybacks / free cash flow | 5.1% | 80.9% | — | — | 73.4% | 629.8% | 183.1% | 140.7% | 166.2% | — |
| Capex / revenue | 5.7% | 1.5% | 1.7% | 5.3% | 3.1% | 5.7% | 1.5% | 2.4% | 1.9% | 3.9% |
| Capex / operating cash flow | 23.5% | 29.1% | 68.3% | — | 16.2% | 42.4% | 5.1% | 5.6% | 4.9% | 7.3% |
| Capex / depreciation | 1.36 | 0.47 | 0.32 | 0.73 | 0.41 | 0.63 | 0.16 | 0.25 | 0.24 | 0.42 |
| Stock-based compensation / revenue | 10.9% | 7.1% | 13.8% | 8.6% | 15.6% | 14.3% | 9.8% | 8.0% | 8.1% | 8.8% |
| R&D / revenue | 38.8% | 36.7% | 41.9% | 32.7% | 28.9% | 26.9% | 30.7% | 29.2% | 23.2% | 25.4% |
| SG&A / revenue | 28.0% | 22.4% | 29.0% | 22.5% | 24.7% | 25.0% | 20.5% | 18.2% | 7.1% | 19.4% |
| Efficiency | ||||||||||
| Days sales outstanding | 88.2 | 68.3 | 65.9 | 50.4 | 45.0 | 63.8 | 83.0 | 96.3 | 96.3 | 95.4 |
| Days of inventory on hand | — | — | 12.5 | -0.0 | — | 0.0 | — | — | — | — |
| Days payables outstanding | 12.6 | 42.5 | 49.2 | 37.0 | 32.2 | 38.1 | 37.3 | 23.5 | 28.7 | 34.6 |
| Cash conversion cycle (days) | 75.6 | 25.8 | 29.2 | 13.5 | 12.8 | 25.7 | 45.7 | 72.7 | 67.7 | 60.8 |
| Receivables turnover | 4.14 | 5.35 | 5.54 | 7.24 | 8.11 | 5.72 | 4.40 | 3.79 | 3.79 | 3.83 |
| Payables turnover | 28.94 | 8.59 | 7.42 | 9.88 | 11.33 | 9.58 | 9.79 | 15.50 | 12.73 | 10.55 |
| Inventory turnover | — | — | 29.13 | — | — | 120,395,000.00 | — | — | — | — |
| Asset turnover | 0.38 | 0.33 | 0.23 | 0.22 | 0.23 | 0.21 | 0.21 | 0.20 | 0.19 | 0.16 |
| Average receivables | $60.8M | $62.0M | $53.2M | $45.3M | $47.8M | $57.9M | $68.9M | $73.1M | $64.6M | $55.2M |
| Average payables | $2.4M | $10.4M | $13.6M | $11.0M | $10.0M | $12.6M | $11.6M | $6.0M | $6.0M | $6.5M |
| Average inventory | — | — | $3.5M | −$1 | — | $1 | — | — | — | — |
| Intangibles / total assets | 47.4% | 42.5% | 69.7% | 68.3% | 67.6% | 69.6% | 79.9% | 86.2% | 84.3% | 87.3% |
Computed from CRNC's annual financial statements (latest annual report filed November 20, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CRNC valuation and financial ratios
Cerence earned a return on equity of −12.8% and a return on invested capital of 3.4% in fiscal 2025. It ended the year with $230.3 million of debt and $87.5 million in cash and short-term investments, net debt of $142.8 million. It returned $2.4 million to shareholders: $0 in dividends and $2.4 million in share buybacks, 5% of free cash flow. The share count rose 18.7% from 36.4M to 43.2M over 9 years.
See the CRNC income statement, the CRNC chart for price history, or the CRNC stock overview for the latest quote and news.
CRNC key metrics FAQ
What is Cerence's EV/EBITDA?
Cerence's enterprise value was 57.0 times EBITDA at the end of fiscal 2025 (enterprise value $680.8 million, EBITDA $12.0 million); the current EV/EBITDA is 10.8.
What is Cerence's return on equity?
Cerence's return on equity (ROE) was −12.8% in fiscal 2025: net income of -$18.7 million on average shareholders' equity of $145.9 million.
What is Cerence's ROIC?
Cerence's return on invested capital was 3.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Cerence have?
Cerence had total debt of $230.3 million at the end of fiscal 2025, a debt-to-equity ratio of 1.53 and $142.8 million of net debt (11.95 times EBITDA).
Does Cerence buy back its shares?
Yes. Cerence spent $2.4 million on net share repurchases in fiscal 2025 Shares outstanding changed +3.7% over the year, to 43.2M..
What is Cerence's free cash flow yield?
Cerence generated $46.8 million of free cash flow in fiscal 2025, a free cash flow yield of 8.7% on its market value at year-end ($538.0 million).
What is Cerence's current ratio?
Cerence's current ratio was 1.84 at the end of fiscal 2025: current assets were 1.84 times current liabilities.